Loading...

A Phase II Trial of Pazopanib in Patients with Metastatic Alveolar Soft Part Sarcoma

LESSONS LEARNED. Pazopanib shows a modest efficacy in metastatic alveolar soft part sarcoma. Clinical outcomes were comparable to those in previous studies using antiangiogenic drugs. Further prospective studies evaluating the benefit of pazopanib in alveolar soft part sarcoma with a larger sample a...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Oncologist
Main Authors: Kim, Miso, Kim, Tae Min, Keam, Bhumsuk, Kim, Yu Jung, Paeng, Jin Chul, Moon, Kyung Chul, Kim, Dong‐Wan, Heo, Dae Seog
Format: Artigo
Sprog:Inglês
Udgivet: John Wiley & Sons, Inc. 2018
Fag:
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324645/
https://ncbi.nlm.nih.gov/pubmed/30254189
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2018-0464
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!